Paradigm Medical Industries, Inc.
PDMI
$0.0001
$0.000.00%
OTC PK
| 03/31/2012 | 09/30/2011 | 06/30/2011 | 03/31/2011 | ||
|---|---|---|---|---|---|
| Revenue | -7.65% | 15.56% | 9.70% | 56.80% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -7.65% | 15.56% | 9.70% | 56.80% | |
| Cost of Revenue | -26.39% | -43.75% | 100.00% | 14.29% | |
| Gross Profit | 3.23% | 83.33% | -15.24% | 100.00% | |
| SG&A Expenses | -52.40% | -61.20% | -21.67% | 8.33% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -39.00% | -62.36% | -9.75% | 7.16% | |
| Operating Income | 76.69% | 114.50% | 21.33% | 22.38% | |
| Income Before Tax | 66.15% | 101.37% | 34.85% | 67.98% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 66.15% | 101.37% | 34.85% | 67.98% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 66.15% | 101.37% | 34.85% | 67.98% | |
| EBIT | 76.69% | 114.50% | 21.33% | 22.38% | |
| EBITDA | 77.16% | 114.61% | 21.33% | 22.49% | |
| EPS Basic | 100.00% | 100.00% | 84.75% | 96.17% | |
| Normalized Basic EPS | 100.00% | 100.00% | 83.78% | -- | |
| EPS Diluted | 100.00% | 100.00% | 84.75% | 96.17% | |
| Normalized Diluted EPS | 100.00% | 100.00% | 83.78% | -- | |
| Average Basic Shares Outstanding | 1,216.34% | 5,502.49% | 325.61% | 711.30% | |
| Average Diluted Shares Outstanding | 1,216.34% | 5,502.49% | 325.61% | 711.30% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |